Exceptional Responses to Selpercatinib in RET Fusion-Driven Metastatic Pancreatic Cancer

Affiliations

• ¹ Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
• ² Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
• ³ Department of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
• ⁴ Medical Science Academy, Hightower High School, Houston, TX.
• ⁵ Peggy and Charles Stephenson Cancer Center and the Department of Pathology, The University of Oklahoma Health Science Center, Oklahoma City, OK.
• ⁶ Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
• ⁷ Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
• ⁸ MD Anderson Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, TX.
• ⁹ Sarah Cannon Research Institute, Nashville, TN.